Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Natrol Q2 earnings

This article was originally published in The Tan Sheet

Executive Summary

Natrol reported net income of $100,000 on net sales of $16.6 mil. during the second-quarter (ended June 30) marking the company's "second consecutive quarter of profitability," Natrol President and CEO Wayne Bos said Aug. 14. The gains represented a turnaround from the first two quarters of 2005 when Natrol reported a net loss of $300,000 on net sales of $37.3 mil. "We have achieved profitability by being sharply-focused on the core business," Bos said...

You may also be interested in...



Natrol Sees More Deals In The Future; Looks To Tailor, Balance Portfolio

An exclusive manufacturing and distribution deal with H57 Nutrition for Original South African H57 Hoodia is a feather in Natrol's cap following several acquisitions and licensing deals in the past three weeks

Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge

Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."

Topics

UsernamePublicRestriction

Register

PS099679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel